Sanofi Ventures
Venture capital firm · Founded 2012 · Paris, France · Paris ↗
Sanofi Ventures is the evergreen corporate venture capital arm of Sanofi, investing since 2012 in biotech and AI/digital health companies aligned with Sanofi's focus on immunology, rare diseases, neurology and vaccines; it has deployed more than $800 million across more than 70 companies, and a further $625 million commitment in September 2025 took its assets under management above $1.4 billion.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at Sanofi Ventures, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$1.4B
Latest fund
LAST CHECKED NOV 2026
Funds
LAST CHECKED NOV 2026
Check size
$5M–$15M
Stages
GrowthSeedSeries ASeries B
Sectors
BiotechDigital Health
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
Track record
Misses
Track record
Partners 6
Christopher GagliardiPrincipal
Board seats
No public record
Jason P. HaflerManaging Director
Board seats
No public record
Laia CrespoPartner
Board seats
No public record
Cris De LucaPartner
Board seats
No public record
Paulina HillPartner
Board seats
1 current
Meg KrenchPrincipal
Board seats
No public record
Reputation 2
No reputation score — basis not established for this firm.
Contact
Published sources only
Published contact
- Website
- www.sanofiventures.com/home/
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Sanofi Ventures. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — T3: assets under management above $1.4B (already in production; corroborated by Sanofi's September 2025 press release) sit in the $500M-$2B band. Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for Sanofi Ventures — provenance: GlassVC catalog census, November 2026
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Reputation
- [2]
FIRM SITE · Sanofi Ventures — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
